<DOC>
	<DOCNO>NCT01311674</DOCNO>
	<brief_summary>The purpose study vaccinate plasmapheresis donor collection high titer plasma use manufacture Hepatitis B Immune Globulin ( HBIG ) .</brief_summary>
	<brief_title>Hepatitis B Virus ( HBV ) Antibody ( Anti-HBs ) Booster Program Production Hepatitis B Immune Globulin ( HBIG )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<criteria>Age 2055 year Naive previously hepatitis Bvaccinated male females Normal healthy determine medical history , physical exam , vital sign clinical laboratory test Subject must meet required/recommended subject suitability criterion pertain normal source plasma donor follow exception . Subjects previously test positive HBsAg may accept antiHBs program provide test negative meet normal donor suitability criterion . Written informed consent . Subjects receive hepatitis vaccination previous six month . History hypersensitivity yeast component EngerixBÂ® vaccine . History hypersensitivity hepatitis Bcontaining vaccine . Use investigational product within past 30 day course study . Use steroids immunosuppressive study period . Subjects receive immunosuppressive therapy ( include systemic steroid ) within 30 day study entry Subjects receive cytotoxic therapy ( previous 5 year prior study entry ) Received parenteral immune globulin product blood product within 3 month study entry follow exception ( specify plasma center procedure ) : Rho ( D ) immune globulin ( e.g . RhoGAM WinRho ) within 6 week study entry ; Pertussis immune globulin : exclusion Past , present , suspect IV drug use Positive HIV , HBV* HCV test result ( *except describe Inclusion Criteria section ) Subjects autoimmune disease ( , limit demyelinate disease ) Subjects cancer , heart disease ( include hospitalization myocardial infarction , arrhythmia , syncope , congestive heart failure ) , uncontrolled hypertension , uncontrolled insulindependent diabetes mellitus , seizure , kidney disease Severely morbidly obese , high obesity classification , correspond BMI 35 high Pregnancy lactation ( female must negative pregnancy test prior vaccination ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>